Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and.

Slides:

Advertisements

Similar presentations

Intermediate stage HCC management

Advertisements

Staging Strategy and Treatment for Patients With HCC

High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.

Interventional Oncology Michael Kotton MD October 27, 2012.

Journal Meeting 時間 : AM 07:30 日期 : 06/29/2007 地點 : 胸腔外科辦公室報告人 : R2 許博順.

Dr SH Chok Department of Surgery Ruttonjee & Tang Shiu Kin Hospitals

HCC Guidelines and recommendation Typical feature (wash in/wash out) New mass/nodule NoYes Alternative imaging technique Atypical featureTypical.

57445 HCC were registered HCC with complete data underwent surgical resection 9577 underwent local ablation therapies 9283 underwent TACE 1150.

HEPATOCELLULAR CARCINOMA Monton. HCC in Thailand Most common cancer in Thai male Incidence 5 x 100,000 / year Male : female = 3-8:1 Age > 40 yr.

Hepatocellular Carcinoma and Liver Transplantation TTS Key Opinion Leaders Meeting Montreal, April 2007 Mazen Hassanain MBBS, FRCS(C) Assistant Professor.

Diagnosing and Managing Cancers of the Liver and Bile Ducts Jeffrey S. Weinstein, MD Medical Director of Liver Transplantation Methodist Dallas Medical.

Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation Neil Mehta, MD; Jennifer Guy,

Improved Survival of Hepatocellular Carcinoma (HCC) in HIV-Infected Patients with Undetectable HIV RNA Oral Poster Presentation Tuesday, 20 July 2010 Emma.

Hepatocellular carcinoma related to Hbv and Hcv

Phase I evaluation of sorafenib & bevacizumab as first-line therapy in hepatocellular cancer (HCC) Joleen M. Hubbard 1, Steven R. Alberts 1, William S.

HCC Guidelines and recommendation Diagnostic algorithm and recall policy.*One imaging technique only recommended in centers of excellence with high-end.

A2ALL When Using A2ALL Slides We welcome the use of A2ALL slides, as we value the distribution of our research for the benefit of patient care and transplant.

Treatment Strategy for Recurrent Hepatocellular Carcinoma: Salvage Transplantation, Repeated Resection, or Radiofrequency Ablation? Albert C. Y. Chan,

Management of Hepatocellular carcinoma

Dustin Thompson, MD Associate Staff | Interventional Radiology

Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),

Hepatocellular Carcinoma: Diagnosis and Management

Liver Transplantation – ‘who needs a liver transplant’

The ART of Decision Making : Retreatment with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Wolfgang Sieghart, Florian Hucke,

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

Oncology Grand Rounds “Non-surgical Management of

Cancer Hospital & Institute, Chinese Academy of Medical Sciences

Treatment of hepatocellular carcinoma

Volume 56, Issue 4, Pages (April 2012)

Fig. 3. Comparative RFS in response to combination of RFA and TACE vs

Algorithm for the management of hepatocellular carcinoma (HCC)

Algorithm for the management of hepatocellular carcinoma (HCC)

Fig. 4. HCC with hepatobiliary phase (HBP) capsule appearance in 59-year-old female hepatitis B virus carrier. A. 2.8-cm tumor (arrow) in right posterior.

Barcelona Clinic Liver Cancer (BCLC) staging classification and treatment schedule. Patients with very early hepatocellular carcinoma (HCC) (stage 0) are.

T7-005 Survival and Prognostic Factors for Patients with Advanced Hepatocellular Carcinoma after Stereotactic Ablative Radiotherapy Wen-Yen Huang (黃文彥),

What does this protein make up or do?

Multidisciplinary Management of Hepatocellular Carcinoma

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

Journal Club Leona von Köckritz

Focus on hepatocellular carcinoma

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals Liver Cancer - DOI: / Fig. 1. Flowchart of included.

Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Hepatocellular Carcinoma: Overcoming Challenges in Disease Management

Fig. 1. HCC in 56-year-old man. A

Volume 68, Issue 4, Pages (April 2018)

ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable? Jian Wu, Wei Bai,

Clinical algorithm of diagnosis and treatment of bone metastasis guideline. Clinical algorithm of diagnosis and treatment of bone metastasis guideline.

Volume 69, Issue 1, Pages (July 2018)

Treatment of hepatocellular carcinoma

Volume 57, Issue 4, Pages (October 2012)

Epidemiology & First option of treatment

Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C

Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic

Diagnosis and Treatment of Hepatocellular Carcinoma

KAHBPS , Gyeongju, Korea Long-term outcome after resection of huge hepatocellular carcinoma ≥10 cm: Single-institution experience with 471 patients:

Evolution of liver transplantation for hepatocellular carcinoma

Combined locoregional-immunotherapy for liver cancer

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Liver Transplantation for Hepatocellular Carcinoma

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular.

Professor of Internal Medicine, HBP unit

Fig. 1. Typical CEUS features of HCC in 60-year-old man with history of right hemihepatectomy for HCC.On arterial (A) and delayed (B) phases of CT, 2.3-cm.

Fig. 6. Gadoxetic acid-enhanced MRI in 70-year-old woman with chronic hepatitis C.On fat-saturated T2-weighted image (A), approximately 5-cm mass (arrow)

Fig. 5. Gadoxetic acid-enhanced MRI in 70-year-old man with CHB

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

Multidisciplinary team approach to hepatocellular carcinoma management in a liver transplant center from Romania Cerban R.1, Iacob S.1, Croitoru A.1, Popescu.

Reversion of disease manifestations after HCV eradication

Friedrich Foerster, Peter Robert Galle JHEP Reports

Presentation transcript:

Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and ECOG performance status 0-1. DDLT = deceased donor LT, EBRT = external-beam radiation therapy, ECOG = Eastern Cooperative Oncology Group, HCC = hepatocellular carcinoma, KLCSG = Korean Liver Cancer Study Group, LDLT = living donor liver transplantation, LT = liver transplantation, mUICC = modified Union for International Cancer Control, NCC = National Cancer Center, PEIT = percutaneous ethanol injection therapy, RFA = radiofrequency ablation, TACE = transarterial chemoembolization, VI = vascular or bile duct invasion Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and ECOG performance status 0-1. DDLT = deceased donor LT, EBRT = external-beam radiation therapy, ECOG = Eastern Cooperative Oncology Group, HCC = hepatocellular carcinoma, KLCSG = Korean Liver Cancer . . . Korean J Radiol. 2015 May-Jun;16(3):465-522. http://dx.doi.org/10.3348/kjr.2015.16.3.465